Bioelectronics Corp (BIEL)

[art2426]

Ok, that's what I thought might happen. Since they have stated previously they have accepted the data on the knee and foot (insole), I felt they just might give the clearance for sales on those two products first. Wait later for more statistics from Bioelectronics on the back pain studies and OK that use at a later date. This long delay gave me the thought that it was due to their in house decision to wait for that back pain information and give a 'one for all (uses)' OK. Since the products work on the same principle, I felt that was going to be the word from the FDA. Giving the OK on the insole and knee patch first is fine with me, if true, and maybe better as we get another boost afterwards with word of back patch approved. We will have to just wait and see

As far as prescription, they are all available as of now for just that if I am correct.